BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• 

  COVID-19

  Novavax Catches Up to Competitors With FDA Approval for Updated COVID-19 Boosters

  Unlike Pfizer/BioNTech and Moderna, Novavax does not use mRNA technology for its COVID-19 vaccine, instead opting for a recombinant version of the virus’ spike protein to elicit protection.

  September 3, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Clinical research

  Bayer’s Kidney Disease Drug Kerendia Reduces Cardiovascular Risk by 16%

  Bayer’s Kerendia, at the center of a $3 billion sales forecast, reduced the risk of cardiovascular death and heart failure in a Phase III trial.

  September 3, 2024

   · 

  2 min read

   · 

  Annalee Armstrong
• Press Releases

  Obsidian Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for OBX-115 for the Treatment of Advanced Melanoma

  September 3, 2024

   · 

  3 min read
• Press Releases

  JOHN BALLANTYNE, FORMER BIOTECHNOLOGY EXECUTIVE, JOINS THE GLUCOTRACK BOARD OF DIRECTORS

  September 3, 2024

   · 

  4 min read
• Press Releases

  INmune Bio Inc. to Present at the Baird 2024 Global Healthcare Conference

  September 3, 2024

   · 

  3 min read
• Press Releases

  Petros Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference

  September 3, 2024

   · 

  1 min read
• Press Releases

  Vertica by Ohh-Med Medical Secures First Insurance Reimbursement

  September 3, 2024

   · 

  3 min read
• Press Releases

  Nektar Management to Present at Upcoming Investor Conferences

  September 3, 2024

   · 

  1 min read
• 

  Press Releases

  Cell Therapy Human Raw Materials Market to Hit $22.75 Bn in 2034 Amid Rapid Growth

  September 3, 2024

   · 

  12 min read
• Press Releases

  AZURITY PHARMACEUTICALS, INC. ANNOUNCES FDA APPROVAL OF NYMALIZE® (NIMODIPINE) ORAL SOLUTION 30 MG/5 ML PREFILLED ENFIT® SYRINGE

  September 3, 2024

   · 

  3 min read